Why agilon health, inc.’s (AGL) Stock Is Down 5.24%
As of Monday, August 31, agilon health, inc.’s AGL share price has dipped by 5.24%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Commentary & Analysis
Why agilon health, inc.’s (AGL) Stock Is Up 5.01%
As of Friday, August 14, agilon health, inc.’s AGL share price has surged by 5.01%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why agilon health, inc.’s (AGL) Stock Is Up 5.07%
As of Monday, August 10, agilon health, inc.’s AGL share price has surged by 5.07%, which has investors questioning if this is right time to sell.Jenna Brashear
Why agilon health, inc.’s (AGL) Stock Is Up 7.32%
As of Friday, August 07, agilon health, inc.’s AGL share price has surged by 7.32%, which has investors questioning if this is right time to sell.Michael Rose
Why agilon health, inc.’s (AGL) Stock Is Up 10.47%
As of Friday, August 07, agilon health, inc.’s AGL share price has surged by 10.47%, which has investors questioning if this is right time to sell.Omar Beirat
Financial Summary
| Share Statistics | AGL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,546.8 | $1,825.3 | 51% |
|
| Shares Out (Mil) | 17.2 | 73.7 | 28% |
|
| Institutional Ownership | 96.6% | 86.9% | 70% |
|
| Float (Mil) | 10.9 | 56.1 | 20% |
|
| Beta | 3.05 | 0.75 | 98% |
|
| Avg Daily Volume (000s) | 169 | 522 | 42% |
|
| Price Change (52-week) |
244.4% | 80.0% | 98% |
|
| Growth | AGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 37.2% | 10.6% | 92% |
|
| Net Income (5yr) | (45.5%) | (0.1%) | 8% |
|
| EPS (5yr) | (38.5%) | 3.1% | 6 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (19.5%) | (17.7%) | 34% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | na | 7 | |
| Current EPS | ($0.754) | na | $2.663 | |
| Month Ago EPS | ($0.754) | na | $1.765 | |
| # Rev Up | 0 | na | 1 | |
| # Rev Down | 1 | na | 0 | |
| Three Months Ago EPS | ($0.649) | na | ($0.617) | |
| Year/Year Chg | (172.5%) | na | (122.1%) | |
| Financials | AGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5,920 | $1,503 | 77% |
|
| Net Income (TTM) (Mil) | ($232) | $26 | 6% |
|
| EPS (TTM) | ($13.974) | $0.200 | 4% |
|
| Operating Cash Flow (TTM) (Mil) | ($72) | $157 | 7% |
|
| Net Cash Flow (TTM) (Mil) | na | $8 | na |
|
| Long-Term Debt (Q1) (Mil) | $19 | $356 | 32% |
|
| Enterprise Value (Q1) (Mil) | $1,298 | $2,338 | 43% |
|
| Valuation | AGL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.79 | 3.06 | 85% |
|
| P/E | na | 25.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | AGL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 0.2% | 27.9% | 4% |
|
| Net Margin | (3.9%) | 1.3% | 26% |
|
| ROA | (14.1%) | 2.2% | 23% |
|
| ROE | (73.0%) | 7.0% | 12% |
|
| Liabilities to Assets | 85.7% | 60.8% | 79% |
|
| F-Score | 4 | 5 | 33% |
|
Passing Stock Screens
As of 9/15/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
O'Shaughnessy: Growth Screen II
Factors: Value, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 15.0% |
| +/- S&P 500: | +7.5 |
